SEC Form 4 · accession 0001618835-18-000092
Evofem Biosciences, Inc. · EVFM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alexander A Fitzpatrick
Officer — General Counsel and Secretary
Period of report
Oct 16, 2018
Accepted (ET)
Oct 17, 2018 · 12:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618835
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 16, 2018 | F | 17,377 | $3.78 | D | 57,623 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares withheld by the Issuer to satisfy statutory tax withholding requirements upon vesting of restricted stock awards occurring on October 16, 2018. No shares were sold in connection with this transaction.